Lixte Biotechnology Holdings Inc (LIXT)
1.60
-0.04
(-2.44%)
USD |
NASDAQ |
Nov 14, 16:00
1.64
+0.04
(+2.50%)
After-Hours: 20:00
Lixte Biotechnology Holdings Free Cash Flow (Quarterly): -0.819M for June 30, 2024
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | -0.819M |
| March 31, 2024 | -0.7892M |
| December 31, 2023 | -0.9021M |
| September 30, 2023 | -0.9444M |
| June 30, 2023 | -1.175M |
| March 31, 2023 | -1.271M |
| December 31, 2022 | -1.208M |
| September 30, 2022 | -1.174M |
| June 30, 2022 | -1.194M |
| March 31, 2022 | -1.035M |
| December 31, 2021 | -1.147M |
| September 30, 2021 | -0.9279M |
| June 30, 2021 | -1.042M |
| March 31, 2021 | -1.026M |
| December 31, 2020 | -0.739M |
| September 30, 2020 | -0.6237M |
| June 30, 2020 | -0.3546M |
| March 31, 2020 | -0.414M |
| December 31, 2019 | -0.3775M |
| September 30, 2019 | -0.5876M |
| June 30, 2019 | -0.3296M |
| March 31, 2019 | -0.3794M |
| December 31, 2018 | -0.5766M |
| September 30, 2018 | -0.1646M |
| June 30, 2018 | -0.272M |
| Date | Value |
|---|---|
| March 31, 2018 | -0.4977M |
| December 31, 2017 | -0.2843M |
| September 30, 2017 | -0.4604M |
| June 30, 2017 | -0.3384M |
| March 31, 2017 | -0.329M |
| December 31, 2016 | -0.4698M |
| September 30, 2016 | -0.4801M |
| June 30, 2016 | -0.4016M |
| March 31, 2016 | -0.3259M |
| December 31, 2015 | -0.6123M |
| September 30, 2015 | -0.5089M |
| June 30, 2015 | -0.5213M |
| March 31, 2015 | -0.5386M |
| December 31, 2014 | -0.6444M |
| September 30, 2014 | -0.3378M |
| June 30, 2014 | -0.2937M |
| March 31, 2014 | -0.3596M |
| December 31, 2013 | -0.316M |
| September 30, 2013 | -0.2844M |
| June 30, 2013 | -0.2992M |
| March 31, 2013 | -0.2805M |
| December 31, 2012 | -0.2257M |
| September 30, 2012 | -0.2959M |
| June 30, 2012 | -0.4353M |
| March 31, 2012 | -0.249M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-1.271M
Minimum
Mar 2023
-0.3546M
Maximum
Jun 2020
-0.9034M
Average
-0.9444M
Median
Sep 2023
Free Cash Flow (Quarterly) Benchmarks
| Shuttle Pharmaceuticals Holdings Inc | -1.399M |
| Soligenix Inc | -1.918M |
| Tonix Pharmaceuticals Holding Corp | -9.919M |
| NovaBay Pharmaceuticals Inc | -2.063M |
| Palatin Technologies Inc | -6.477M |